Are breast cancers driven by fusion genes?

Breast Cancer Research

Volumn 14, Issue 2, 2012, Pages

  Edwards, Paul A W ^a   Howarth, Karen D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; ESTROGEN RECEPTOR; HYBRID PROTEIN; IMATINIB; MICROTUBULE ASSOCIATED PROTEIN; NOTCH RECEPTOR; SEC16A NOTCH1 FUSION PROTEIN; UNCLASSIFIED DRUG; NOTCH1 PROTEIN, HUMAN; NOTCH1 RECEPTOR; PROTEIN SERINE THREONINE KINASE; SEC16A PROTEIN, HUMAN; VESICULAR TRANSPORT PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA SEQUENCE; DRUG TARGETING; FUSION GENE; GENE DELETION; GENE FUSION; GENE MUTATION; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SEQUENCING; HUMAN; POINT MUTATION; PROSTATE CANCER; BREAST TUMOR; FEMALE; GENETICS; MALE; PROSTATE TUMOR;

BREAST NEOPLASMS; FEMALE; FUSION PROTEINS, BCR-ABL; GENE FUSION; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, NOTCH1; VESICULAR TRANSPORT PROTEINS;

EID: 84858448028     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3122     Document Type: Article

References (15)

1. Robinson DR, Kalyana-Sundaram S, Wu YM, Shankar S, Cao X, Ateeq B, Asangani IA, Iyer M, Maher CA, Grasso CS, Lonigro RJ, Quist M, Siddiqui J, Mehra R, Jing X, Giordano TJ, Sabel MS, Kleer CG, Palanisamy N, Natrajan R, Lambros MB, Reis-Filho JS, Kumar-Sinha C, Chinnaiyan AM. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat Med 2011, 17:1646-1651. 10.1038/nm.2580, 22101766.
2. Edwards PAW. Fusion genes and chromosome translocations in the common epithelial cancers. J Pathol 2010, 220:244-254.
3. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005, 310:644-648. 10.1126/science.1117679, 16254181.
4. Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007, 7:233-245. 10.1038/nrc2091, 17361217.
5. Hantschel O, Superti-Furga G. Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat Rev Mol Cell Biol 2004, 5:33-44. 10.1038/nrm1280, 14708008.
6. Beissert T, Puccetti E, Bianchini A, Güller S, Boehrer S, Hoelzer D, Ottmann OG, Nervi C, Ruthardt M. Targeting of the N-terminal coiled coil oligomerization interface of BCR interferes with the transformation potential of BCR-ABL and increases sensitivity to STI571. Blood 2003, 102:2985-2993. 10.1182/blood-2003-03-0811, 12829585.
7. Druker BJ, Lydon NB. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Invest 2000, 105:3-7. 10.1172/JCI9083, 382593, 10619854.
8. Hampton OA, Den Hollander P, Miller CA, Delgado DA, Li J, Coarfa C, Harris RA, Richards S, Scherer SE, Muzny DM, Gibbs RA, Lee AV, Milosavljevic A. A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. Genome Res 2009, 19:167-177. 2652200, 19056696.
9. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, Stebbings LA, Leroy C, Edkins S, Mudie LJ, Greenman CD, Jia M, Latimer C, Teague JW, Lau KW, Burton J, Quail MA, Swerdlow H, Churcher C, Natrajan R, Sieuwerts AM, Martens JW, Silver DP, Langerød A, Russnes HE, Foekens JA, Reis-Filho JS, van 't Veer L, Richardson AL, Børresen-Dale AL, et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 2009, 462:1005-1010. 10.1038/nature08645, 20033038.
10. Zhao Q, Caballero OL, Levy S, Stevenson BJ, Iseli C, de Souza SJ, Galante PA, Busam D, Leversha MA, Chadalavada K, Rogers YH, Venter JC, Simpson AJ, Strausberg RL. Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line. Proc Natl Acad Sci USA 2009, 106:1886-1891. 10.1073/pnas.0812945106, 2633215, 19181860.
11. Hampton OA, Miller CA, Koriabine M, Li J, Den Hollander P, Carbone L, Nefedov M, Ten Hallers BF, Lee AV, De Jong PJ, Milosavljevic A. Long-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell lines. Cancer Genet 2011, 204:447-457. 10.1016/j.cancergen.2011.07.009, 21962895.
12. Inaki K, Hillmer AM, Ukil L, Yao F, Woo XY, Vardy LA, Zawack KF, Lee CW, Ariyaratne PN, Chan YS, Desai KV, Bergh J, Hall P, Putti TC, Ong WL, Shahab A, Cacheux-Rataboul V, Karuturi RK, Sung WK, Ruan X, Bourque G, Ruan Y, Liu ET. Transcriptional consequences of genomic structural aberrations in breast cancer. Genome Res 2011, 21:676-687. 10.1101/gr.113225.110, 3083084, 21467264.
13. Howarth KD, Blood KA, Ng BL, Beavis JC, Chua Y, Cooke SL, Raby S, Ichimura K, Collins VP, Carter NP, Edwards PA. Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes. Oncogene 2008, 27:3345-3359. 10.1038/sj.onc.1210993, 2423006, 18084325.
14. Mitelman F, Johansson B, Mertens F. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet 2004, 36:331-334. 10.1038/ng1335, 15054488.
15. Mitelman F, Mertens F, Johansson B. Prevalence estimates of recurrent balanced cytogenetic aberrations and gene fusions in unselected patients with neoplastic disorders. Genes Chromosomes Cancer 2005, 43:350-366. 10.1002/gcc.20212, 15880352.